SFX by Ex Libris Inc.

Title:	Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
Source:	Nature [0028-0836] Peng, D yr:2015

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Vire, E. "The Polycomb group protein EZH 2 directly controls DNA methylation." Nature 439.7078 (2006): 871-874.
description	2.	Maillard, I. "Metabolism: Inflammation keeps old mice healthy." Nature 528.7580 (2015): 44-6.
description	3.	Rozhok, Andrii I. "A Critical Examination of the "Bad Luck" Explanation of Cancer Risk." Cancer prevention research 8.9 (2015): 762-4.
description	4.	Reményi, P. "Peripheral Blood Stem Cell Mobilization and Engraftment after Autologous Stem Cell Transplantation with Biosimilar rhG-CSF." Advances in therapy 31.4 (2014): 451-460.
description	5.	Soriano, F G G. "Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly (ADP-ribose) polymerase activation." Journal of molecular medicine 79.8 (2001): 437-48.
description	6.	van Lohuizen, M. "Developmental biology: two paths to silence merge." Nature 439.7078 (2006): 794-5.
description	7.	de la Cruz, Cecile C C. "The polycomb group protein SUZ12 regulates histone H3 lysine 9 methylation and HP1 alpha distribution." Chromosome research 15.3 (2007): 299-314.
description	8.	Soriano, L G. "Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation." Nature medicine 7.1 (2001): 108-13.
description	9.	Derényi, I. "Hierarchical tissue organization as a general mechanism to limit the accumulation of somatic mutations." Nature Communications 8 (2017): 14545-14545.
description	10.	Peters, E. "Cancer and “Bad Luck”: Risk Perception, Decision Making, and Risk-Reducing Behavior." Risk analysis 35.4 (2015): 558-559.
description	11.	Greaves, M. "Evolutionary Determinants of Cancer." Cancer discovery 5.8 (2015): 806-820.
description	12.	Kon Kim, T. "Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions." Seminars in hematology 52.3 (2015): 172-83.
description	13.	Reilly, Shannon M. "Countering inflammatory signals in obesity." Nature Immunology 15.5 (2014): 410-411.
description	14.	Sledge, George W. "MUSINGS OF A CANCER DOCTOR." Oncology times 35.18 (2013): 25-26.
description	15.	Odegaard, Justin I. "Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis." Science 339.6116 (2013): 172-177.
description	16.	Acevedo, Nuria C. "Impact of starch gelatinization on the kinetics of Maillard reaction in freeze-dried potato systems." Food and Bioprocess Technology 5.6 (2012): 2428-2434.
description	17.	Bissell, Mina J. "Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression." Nature medicine 17.3 (2011): 320-329.
description	18.	Du, X L L. "Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation." Proceedings of the National Academy of Sciences of the United States of America 97.22 (2000): 12222-6.
description	19.	Gasov, Z. "PBPC collection techniques: standard versus large volume leukapheresis (LVL) in donors and in patients." Transfusion and apheresis science 32.2 (2005): 167-176.
description	20.	Koteja, P. "Maximum cold-induced food consumption in mice selected for high locomotor activity: Implications for the evolution of endotherm energy budgets." The journal of experimental biology 204.6 (2001): 1177-1190.